Psyched: Defense Dept.'s Ketamine Trial, Cybin's Psilocybin, Metabolic Disorders, Reform Update And More - ATAI Life Sciences (NASDAQ:ATAI), Clearmind Medicine (NASDAQ:CMND)
Defense Dept. Funds Ketamine Study For PTSD Treatment 
Enveric Biosciences Incannex Healthcare Clearmind Medicine Seelos Therapeutics Cybin Inc A Psychedelic Therapy Program
Source: benzinga.com